A simple arthritis drug could be an effective, low cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET), a breakthrough study has shown.
Scientists prove low cost arthritis drug can effectively treat blood cancer sufferers
